R. ARIVANANTHAM
CHENNAI, JUNE 15
In a landmark medical breakthrough that promises to redefine the treatment of cardiac rhythm disorders in South India, Kauvery Hospitals has launched two of the world’s most advanced Pulsed Field Ablation (PFA) systems in Chennai, becoming the first hospital in Tamil Nadu to introduce both Medtronic PulseSelect and Biosense Webster Varipulse, including a 3D cardiac mapping-integrated PFA platform.
- Historic launch of Medtronic PulseSelect™ and Biosense Webster Varipulse™ platforms makes Kauvery Hospitals the first in Tamil Nadu to introduce dual next-generation Pulsed Field Ablation systems with advanced 3D cardiac mapping
- Groundbreaking medical feat ushers in a new era of precision cardiac electrophysiology, offering patients minimally invasive treatment with enhanced safety and quicker recovery
- International electrophysiology experts join Chennai specialists as Kauvery Hospitals pioneers transformative technology that selectively targets abnormal heart tissue while preserving vital surrounding structures
- Affordable ‘Heart Rhythm Package’ unveiled alongside cutting-edge programme to promote early diagnosis and timely intervention for patients with potentially life-threatening rhythm disorders
- Innovation reinforces Kauvery Hospitals’ position as a global destination for advanced cardiac care, bringing world-class electrophysiology closer to patients across Tamil Nadu and beyond
The extraordinary medical feat marks a significant leap in the management of atrial fibrillation (AF)—one of the world’s most common and potentially dangerous heart rhythm disorders—and firmly establishes Kauvery Hospitals at the forefront of innovation in cardiac electrophysiology.
Redefining the heartbeat of modern medicine, Kauvery Hospitals has ushered Tamil Nadu into a new era of precision cardiac care by introducing two of the world’s most advanced Pulsed Field Ablation technologies—offering patients safer procedures, faster recovery and renewed hope against complex heart rhythm disorders.
The pioneering programme was inaugurated with the participation of internationally acclaimed electrophysiology experts from the United States, who collaborated with the Kauvery Hospitals team in performing the first procedures and launching the next-generation technology in Chennai.
Unlike conventional ablation procedures that rely on heat or extreme cold to destroy abnormal tissue, Pulsed Field Ablation employs precisely controlled electrical pulses through a process known as electroporation, selectively eliminating the cells responsible for irregular heart rhythms while preserving nearby structures such as the oesophagus, phrenic nerve and blood vessels.
The non-thermal approach significantly enhances procedural safety, efficiency and recovery, making it one of the most promising innovations in modern cardiac care.
With growing international clinical evidence supporting its effectiveness, PFA is increasingly recognised as a transformative advancement in the treatment of cardiac arrhythmias.
The launch ceremony was graced by veteran cardiologist Dr. N.S. Sivakadaksham, who hailed the arrival of the breakthrough technology and underscored its immense potential to improve outcomes for patients suffering from heart rhythm disorders.
On the occasion, he also inaugurated Kauvery Hospitals’ newly introduced “Heart Rhythm Package”—an affordable and comprehensive evaluation programme designed to facilitate early diagnosis and expert management of patients experiencing palpitations, breathlessness, dizziness, unexplained fatigue or episodes of rapid heartbeat.
The initiative seeks to promote timely intervention, which can dramatically improve long-term survival and quality of life.
Sharing the success of the inaugural procedures, Dr. Deep Chandh Raja, Director of Cardiac Electrophysiology, Kauvery Hospitals, said: “Three patients were successfully treated at both centers with these procedures. One of the patients is a 69-year female with recurrent palpitations for 2 years. She tried different medicines for her irregular heart beats without any success. PFA procedure was performed within one hour through a key hole access in the right groin. She got discharged the very next day on minimum medicines. The safety, efficacy and fastness makes PFA a unique technology. We are proud to bring this next-generation treatment to Tamil Nadu.”
Beyond Pulsed Field Ablation, the Department of Cardiac Electrophysiology at Kauvery Hospitals offers comprehensive heart rhythm management through advanced diagnostic services including ECG, Holter monitoring, electrophysiology studies and dedicated arrhythmia clinics.
The department also performs highly specialised procedures such as complex catheter ablations, pacemaker implantation, implantable cardioverter defibrillators and cardiac resynchronisation therapy, supported by state-of-the-art 3D mapping systems and a multidisciplinary team of specialists.
Highlighting the institution’s long-term vision, Dr. Aravindan Selvaraj, Co-Founder and Executive Director, Kauvery Group of Hospitals, said: “At Kauvery Hospitals, we are committed to bringing proven, evidence-based innovations to our patients. Technologies that simplify procedures, enhance safety, and improve outcomes are central to our approach. The introduction of PFA reflects our continued commitment to delivering world-class cardiac care and ensuring access to the latest global advancements.”
By simultaneously introducing both PulseSelect™ and Varipulse™ platforms, Kauvery Hospitals has strengthened its leadership in advanced electrophysiology, offering patients from Tamil Nadu, neighbouring states and overseas access to some of the world’s most sophisticated heart rhythm therapies.
The achievement is more than a technological milestone—it represents a life-saving advancement that combines precision, safety and innovation to transform the future of cardiac care in India.
